Envestnet Portfolio Solutions Inc. Sells 3,844 Shares of Agilent Technologies, Inc. (NYSE:A)

Envestnet Portfolio Solutions Inc. trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 11.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,606 shares of the medical research company’s stock after selling 3,844 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Agilent Technologies were worth $4,112,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Madison Investment Advisors LLC bought a new position in Agilent Technologies in the 4th quarter worth about $94,051,000. Massachusetts Financial Services Co. MA raised its holdings in Agilent Technologies by 3.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after buying an additional 525,214 shares during the last quarter. FMR LLC lifted its stake in shares of Agilent Technologies by 62.2% in the third quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock worth $191,193,000 after buying an additional 493,947 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at approximately $48,172,000. Finally, Worldquant Millennium Advisors LLC purchased a new position in Agilent Technologies in the 3rd quarter worth approximately $49,449,000.

Analyst Ratings Changes

Several analysts have commented on the company. Wells Fargo & Company cut their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 26th. Sanford C. Bernstein decreased their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $135.00 to $145.00 in a report on Monday, February 10th. Finally, Citigroup boosted their price objective on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $146.15.

Agilent Technologies Stock Up 0.5 %

Shares of A stock opened at $123.10 on Wednesday. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a 12 month low of $117.17 and a 12 month high of $155.35. The stock has a market cap of $35.09 billion, a P/E ratio of 28.30, a P/E/G ratio of 3.40 and a beta of 1.11. The company has a 50 day simple moving average of $137.70 and a two-hundred day simple moving average of $137.68.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, research analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.81%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.